153 Results

People

  1. Aghajanian
    Aghajanian
  2. Chi
    Chi
  3. Barakat
    Barakat
  4. Spriggs
    Spriggs
  5. Abu-Rustum
    Abu-Rustum
  6. Seshan
    Seshan
  7. O'Reilly
    O'Reilly
  8. Riely
    Riely
  9. Rosenberg
    Rosenberg
  10. Sabbatini
    Sabbatini

Groups

  1. Department of Medicine (89)
  2. Solid Tumor Oncology Division (83)
  3. Surgery (47)
  4. Gynecology Disease Management Team (30)
  5. Survivorship Research (27)
  6. Epidemiology and Biostatistics (25)
  7. Biostatistics Service (23)
  8. Gynecologic Medicine Service (21)
  9. GDMT, Medicine (20)
  10. Thoracic Oncology (19)
  1. "platinum"
Formats
  1. Journal Article (141)
  2. Review (8)
  3. Conference Paper (1)
  4. Editorial (1)
  5. Guidelines (1)
  6. Meeting Abstract (1)
Groups
  1. Department of Medicine (89)
  2. Solid Tumor Oncology Division (83)
  3. Surgery (47)
  4. Gynecology Disease Management Team (30)
  5. Survivorship Research (27)
  6. Epidemiology and Biostatistics (25)

More Groups

People
  1. Carol Aghajanian (16)
  2. Dennis Chi (13)
  3. David Spriggs (12)
  4. Richard Barakat (12)
  5. Paul Sabbatini (10)
  6. Dean Bajorin (8)

More People

Years
  1. 2025 (6)
  2. 2024 (10)
  3. 2023 (11)
  4. 2022 (2)
  5. 2021 (5)
  6. 2020 (10)

More Years

Publications
  1. Gynecologic Oncology (20)
  2. Journal of Clinical Oncology (16)
  3. Journal of Thoracic Oncology (9)
  4. Cancer (8)
  5. The Oncologist (7)
  6. International Journal of Radiation Oncology, Biology, Physics (5)

More Publications

Publishers
  1. Elsevier Inc. (51)
  2. American Society of Clinical Oncology (17)
  3. Wiley Blackwell (11)
  4. Elsevier Science, Inc. (9)
  5. Oxford University Press (9)
  6. Lippincott Williams & Wilkins (8)

More Publishers

Results (153)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Evaluation of real-world tumor response derived from electronic health record data sources: A feasibility analysis in patients with metastatic non-small cell lung cancer treated with chemotherapy
    Journal Article

    McKelvey, B. A.; Garrett-Mayer, E.; Rivera, D. R.; Alabaster, A.; Andrews, H. S.; Bond, E. G.; Brown, T. D.; Bruno, A.; Damato, L.; Espirito, J. L.; more...
    JCO Clinical Cancer Informatics (2024)

    Fulltext@MSK | Save
  • Exploring the discrepancies between clinical trials and real-world data: A small-cell lung cancer study
    Journal Article

    Marzano, L.; Darwich, A. S.; Dan, A.; Tendler, S.; Lewensohn, R.; De Petris, L.; Raghothama, J.; Meijer, S.
    CTS-Clinical and Translational Science (2024)

    Fulltext@MSK | Save
  • Cancers of unknown primary origin: Real-world clinical outcomes and genomic analysis at the European Institute of Oncology
    Journal Article

    Boscolo Bielo, L.; Belli, C.; Crimini, E.; Repetto, M.; Ascione, L.; Pellizzari, G.; Santoro, C.; Fuorivia, V.; Barberis, M.; Fusco, N.; more...
    The Oncologist (2024)

    Fulltext@MSK | Save
  • Pegargiminase plus first-line chemotherapy in patients with nonepithelioid pleural mesothelioma: The ATOMIC-Meso randomized clinical trial
    Journal Article

    Szlosarek, P. W.; Creelan, B. C.; Sarkodie, T.; Nolan, L.; Taylor, P.; Olevsky, O.; Grosso, F.; Cortinovis, D.; Chitnis, M.; Roy, A.; more...
    JAMA Oncology (2024)

    Fulltext@MSK | Save
  • A somatic BRCA2-mutated pancreatic adenocarcinoma with sustained exceptional response to modified FOLFIRINOX
    Journal Article

    Jamison, J. K.; May, M. S.; Raufi, A. G.; Luk, L.; Wong, W.; Mundi, P. S.; Manji, G. A.
    The Oncologist (2024)

    Fulltext@MSK | Save
  • Phase II DORA study of olaparib with or without durvalumab as a chemotherapy-free maintenance strategy in platinum-pretreated advanced triple-negative breast cancer
    Journal Article

    Tan, T. J.; Sammons, S.; Im, Y. H.; She, L.; Mundy, K.; Bigelow, R.; Traina, T. A.; Anders, C.; Yeong, J.; Renzulli, E.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Effectiveness and safety of camrelizumab-containing neoadjuvant therapy in patients with esophageal squamous cell carcinoma: A prospective multicenter observational cohort study
    Journal Article

    Zhang, Y.; Shen, G.; Xu, R.; Huang, G.; Huang, Z.; Duan, H.; Yang, S.; Zheng, Q.; Yang, L.; Liu, R.; more...
    Journal of Thoracic Disease (2023)

    Fulltext@MSK | Save
  • Few and far between: Clinical management of rare extranodal subtypes of mature T-cell and NK-cell lymphomas
    Review

    Stuver, R.; Epstein-Peterson, Z. D.; Horwitz, S. M.
    Haematologica (2023)

    Fulltext@MSK | Save
  • Outcomes of combination platinum-doublet chemotherapy and anti-PD(L)-1 blockade in KRAS(G12C) mutant non-small cell lung cancer
    Journal Article

    Elkrief, A.; Riccuiti, B.; Alessi, J. V.; Fei, T.; Kalvin, H. L.; Egger, J. V.; Rizvi, H.; Thummalapalli, R.; Lamberti, G.; Plodkowski, A.; more...
    The Oncologist (2023)

    Fulltext@MSK | Save
  • Platinum(IV)–gold(I) agents with promising anticancer activity: Selected studies in 2D and 3D triple-negative breast cancer models
    Journal Article

    López-Hernández, J. E.; Nayeem, N.; Cerón-Carrasco, J. P.; Ahad, A.; Hafeez, A.; León, I. E.; Contel, M.
    Chemistry - A European Journal (2023)

    Fulltext@MSK | Save